NDC 68788-8394-09 - Alprazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8394
- Requested NDC
- 68788-8394-09
- Package NDCs from labels
- 68788-8394-2, 68788-8394-3, 68788-8394-6, 68788-8394-9, 68788-8394-1, 68788-8394-09
- Manufacturer
- PreferredPharmaceuticals Inc. | Preferred Pharmaceuticals Inc.
- Effective date
- 2026-02-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alprazolam - PreferredPharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | PreferredPharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-02-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8394-1 | Alprazolam | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 68788-8394-2 | Alprazolam | 20 in 1 BOTTLE | TABLET | 20 | 4 | |
| 68788-8394-3 | Alprazolam | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 68788-8394-6 | Alprazolam | 60 in 1 BOTTLE | TABLET | 60 | 4 | |
| 68788-8394-9 | Alprazolam | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8394 | ALPRAZOLAM TABLET [PREFERREDPHARMACEUTICALS INC.] | 3 | Current NDC, 5 package rows | 20250119_dc130aae-4510-4de7-a750-4a144e88208d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8394-2 | EA - Each | 68788-8394 | 9b99008f-bec7-4d60-bd49-0e5b4cb11f89 | 1 | 2023-04-07 |
| 68788-8394-3 | EA - Each | 68788-8394 | 227ce36a-9a46-4443-8033-94b48bb71dbc | 1 | 2023-04-07 |
| 68788-8394-6 | EA - Each | 68788-8394 | 0088c842-08e8-4d3e-93e4-3f28f110e002 | 1 | 2023-04-07 |
| 68788-8394-9 | EA - Each | 68788-8394 | 7403df8a-ae8b-4984-9c36-02261dab0e8f | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BEVERHILL HAIR TONIC | UNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATE | BIOHERB Co., Ltd. | 32733977-606e-f110-e063-6294a90aba8f | 2026-11-06 | Warnings | OJ245FE5EU |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 5040e1ed-32d6-4757-a0ee-b8240f3e7cf5 | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 2f16ff78-1262-4bb8-9a25-822c13c4746f | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | F05Q2T2JA0 |
| Docusate Mini Enema | DOCUSATE SODIUM | Major Pharmaceuticals | 91099e15-94d7-b684-e053-2a95a90a574e | 2026-10-23 | Warnings | F05Q2T2JA0 |
| CVS Mini Enema | DOCUSATE SODIUM W/BENZOCAINE | CVS HEALTH | ca00c520-410a-1905-e053-2995a90a56f0 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6a7e4193-22d2-491e-9842-5c43f571fc65 | 2026-10-16 | Warnings | F05Q2T2JA0 |
| MiraSOFT Stool Softener | DOCUSATE SODIUM | Bayer HealthCare LLC. | 5851f15f-8add-559f-e063-6394a90a7b7d | 2026-10-07 | Warnings | F05Q2T2JA0 |
| SENNA-PLUS | SENNOSIDES AND DOCUSATE SODIUM | Preferred Pharmaceuticals Inc. | d7146449-c43e-460a-9ae0-aa1966eaa3b6 | 2026-10-01 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 6484c373-697f-4a81-a375-8cb97223a42c | 2026-09-23 | Warnings | F05Q2T2JA0 |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Right Remedies Stool Softener Clear - Docusate Sodium 50mg softgel | RIGHT REMEDIES STOOL SOFTENER CLEAR SOFTGEL | Strive Pharmaceuticals Inc. | 5b887888-fef3-13cd-e063-6294a90a841e | 2026-09-15 | Warnings | F05Q2T2JA0 |
| Colace | DOCUSATE SODIUM - SENNOSIDES | Atlantis Consumer Healthcare, Inc. | 9fce5c4b-1e2e-47ef-13e5-c3bd5320d41b | 2026-09-09 | F05Q2T2JA0 | |
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 4180a35b-cc50-46ae-a100-99bb218c10ff | 2026-09-09 | Warnings | F05Q2T2JA0 |
| HyVee Regular Strength Stool Softener SOFTGEL | DOCUSATE SODIUM | HyVee Inc | 4971a84b-8a75-c774-e063-6294a90a0fe2 | 2026-09-07 | Warnings | F05Q2T2JA0 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| Kroger Stool Softener Fruit Punch | DOCUSATE SODIUM | KROGER COMPANY | b86f8f3d-594e-466c-854a-b8bff9f7a0b8 | 2026-09-02 | Warnings | F05Q2T2JA0 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Preferred Pharmaceuticals, Inc. | b25b8a28-5e00-4a20-9ca3-7ed494fc4540 | 2026-09-01 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.